Pharmaceutical market access and pricing in Germany underwent a complete remodel with the enactment of AMNOG in 2011. With a few years behind them now, we can look back at their decision track record and gain some valuable insights. Read more here. (Source: Thomas Mittendorf, Xcenda).
You are here: / / Valuable Insights From Germany’s AMNOG – Is It Working?